Category: Other Industries
Country/Region: China State/Province: Liaoning
Main Products: Glargine Insulin
Business Type: Wholesaler, Services
Year Established: 2007
Employees: 5 - 10 People
Plant Area: Below 1,000 square meters
Main Markets: South America 11% Africa 9% Eastern Asia 9% Domestic Market 9% North America 12% Eastern Europe 10% Southern Europe 10% Mid East 12% Northern Europe 9% Oceania 9%
Trade Capacity: FOB, CIP, DAF
Contract Manufacturing: OEM Service Offered Design Service Offered Buyer Label Offered
Nearest Port: Shenyang
Annual Revenue: US$1 Million - US$2.5 Million
Total Revenue: Above US$100 Million
Export Revenue: US$10 Million - US$50 Million
Annual Output: US$10 Million - US$50 Million
Registered Capital: US$50 Million - US$100 Million
Export Percentage: 11% - 20%
Payment Modes: USD, AUD, CHF
Lead Time: 15 days
Import/Export Mode: LLC (Limited Liability Corp)